Neuropace shares owned by Bank of America Corporation
Quarter-by-quarter ownership of Neuropace (NPCE) shares owned by Bank of America Corporation
from 13F filings
Historical chart of Bank of America Corporation investment in Neuropace
Tip: Access up to 7 years of quarterly data
All positions including Neuropace held by Bank of America Corporation consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Neuropace by Bank of America Corporation
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2026-03-31 | $325k | 25k | 13.15 |
| 2024-12-31 | $274k | 24k | 11.19 |
| 2024-09-30 | $93k | 13k | 6.97 |
| 2024-06-30 | $131k | 17k | 7.56 |
| 2024-03-31 | $181k | 14k | 13.20 |
| 2023-12-31 | $329k | 32k | 10.31 |
| 2023-09-30 | $54k | 5.5k | 9.73 |
| 2023-06-30 | $25k | 5.5k | 4.49 |
| 2023-03-31 | $60k | 13k | 4.63 |
| 2022-12-31 | $20k | 13k | 1.50 |
| 2022-06-30 | $16k | 3.2k | 4.91 |
| 2021-12-31 | $69k | 6.9k | 9.99 |
| 2021-06-30 | $48k | 2.0k | 23.64 |
More positions owned by Bank of America Corporation
View all positions for Bank of America Corporation